Humacyte, Inc. (HUMAW) NASDAQ

0.19

-0.0219(-10.28%)

Updated at September 08 04:00PM

Currency In USD

Valuation

Market Cap598.32M
Enterprise Value569.92M
P/E Ratio-3.74
PEG Ratio-0.11
Price/Sales Ratio27.75
Price/Book Ratio54.09
Enterprise/Revenue24.91
Enterprise/EBITDA-5.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-7.29
Operating Margin-13.82

Management Effectiveness

Return On Assets-0.42
Return On Equity3.08

Income Statement

Revenue0
Revenue/Share0.05
Gross Profit-7.19M
EBITDA-132.23M
Net Income-148.7M
Diluted EPS-1.26

Balance Sheet

Total Cash38.03M
Total Cash/Share0.24
Total Debt15.12M
Total Debt/Equity3.73
Current Ratio2.45
Book Value Per Share0.03

Price History

52-Week Change-88.62
52-Week High0.2
52-Week Low0.18
Moving Average 50 Days0.39
Moving Average 200 Days0.86

Statistics

Average Volume21,962.78
Shares Outstanding1.2B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A